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Abstract
Background: Medication adherence remains a difficult problem to both assess and improve in patients. It is a multifactorial
problem that goes beyond the commonly cited reason of forgetfulness. To date, eHealth (also known as mHealth and telehealth)
interventions to improve medication adherence have largely been successful in improving adherence. However, interventions to
date have used time- and cost-intensive strategies or focused solely on medication reminding, leaving much room for improvement
in using a modality as flexible as eHealth.
Objective: Our objective was to develop and implement a fully automated short message service (SMS)-based medication
adherence system, EpxMedTracking, that reminds patients to take their medications, explores reasons for missed doses, and alerts
providers to help address problems of medication adherence in real time.
Methods: EpxMedTracking is a fully automated bidirectional SMS-based messaging system with provider involvement that
was developed and implemented through Epharmix, Inc. Researchers analyzed 11 weeks of de-identified data from patients cared
for by multiple provider groups in routine community practice for feasibility and functionality. Patients included were those in
the care of a provider purchasing the EpxMedTracking tool from Epharmix and were enrolled from a clinic by their providers.
The primary outcomes assessed were the rate of engagement with the system, reasons for missing doses, and self-reported
medication adherence.
Results: Of the 25 patients studied over the 11 weeks, 3 never responded and subsequently opted out or were deleted by their
provider. No other patients opted out or were deleted during the study period. Across the 11 weeks of the study period, the overall
weekly engagement rate was 85.9%. There were 109 total reported missed doses including “I forgot” at 33 events (30.3%), “I
felt better” at 29 events (26.6%), “out of meds” at 20 events (18.4%), “I felt sick” at 19 events (17.4%), and “other” at 3 events
(2.8%). We also noted an increase in self-reported medication adherence in patients using the EpxMedTracking system.
Conclusions: EpxMedTracking is an effective tool for tracking self-reported medication adherence over time. It uniquely
identifies actionable reasons for missing doses for subsequent provider intervention in real time based on patient feedback. Patients
enrolled on EpxMedTracking also self-report higher rates of medication adherence over time while on the system.
(JMIR Res Protoc 2017;6(5):e87)   doi:10.2196/resprot.7223
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As medical innovation continues to give us powerful tools to
treat and prevent disease, one major obstacle between patients
and the benefits of treatment has been medication nonadherence.
Nonadherence rates vary widely among different disease
contexts and patient populations, but estimates of nonadherence
typically range from 50% to 80% [1] with nonadherence notably
elevated in asymptomatic [1] and chronic [2] conditions. This
ultimately has a major impact on clinical outcomes as
nonadherence is estimated to be a major factor in 125,000 deaths
per year [3]. Medication nonadherence is also an important
target for improvement in the context of increasing
cost-containment pressures in the United States. For example,
medication nonadherence has been estimated to cause
approximately 10% of total hospital admissions and results in
an estimated cost to the health care system of $100 to $289
billion annually [3].
Because by definition nonadherence is a problem that occurs
outside of the clinic when patients are away from their providers,
one strategy used to combat this problem in recent years has
been eHealth. eHealth uses telecommunications and computer
technology to enable provider-patient communication across
geographic boundaries [4]. In particular, the growing ubiquity
of telecommunication and mobile devices provides a novel route
for provider-patient interaction at a distance and a powerful tool
to reduce nonadherence. It is estimated that by 2017, 8 billion
mobile phones with short message service (SMS) text messaging
capability will be in use with especially high prevalence in
certain medically vulnerable populations such as minorities and
people in developing countries [5]. The use of basic SMS text
messaging with such devices is an especially attractive option
for eHealth intervention as it offers a familiar, nonintrusive, and
easy-to-use tool for increasing medication adherence.
Prior Work
The use of text messages and phone calls to improve medication
adherence has been extensively studied over the past 15 years,
and one recent meta-analysis found 11 articles using SMS- and
phone call–based interventions showing a cumulative increase
in medication adherence of 22% (risk ratio 1.22, 95% CI
1.09-1.36) [6]. Studies have also shown that SMS text-based
medication reminders can result in significantly higher levels
of medication adherence, fewer hospital admissions, and lower
mortality rates [7,8].
One important concept that has emerged from this literature has
been that technologies that facilitate 2-way communication with
providers are significantly more successful than unidirectional
interventions [9] or simple electronic reminder devices [10].
While it seems clear based on these studies that SMS messages
and phone calls can improve medication adherence, there
remains little evidence about how to best use this methodology.
The vast promise of this methodology hinges on further work
to better understand and refine eHealth techniques and establish
evidence-based protocols.
Theory
In terms of thinking about how an SMS-based system could be
optimized to address medication nonadherence, it may be helpful
to consider the problem in the context of the framework
proposed in the systematic review by Yap et al [11] on the
barriers to medication adherence in older adults, in which they
organize the reasons for nonadherence that have been proven
to date into 5 categories: patient factors, medication factors,
physician factors, system-based factors, and other factors. Many
of the factors they identified include situations and patient
beliefs that could conceivably be identified and addressed by
an SMS- or phone call–based system (see Textbox 1).
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• Poor physical function
• Nonadherence to follow-ups
• Problem drinking
• Beliefs about medication
• Lack of threatening view of illness
• Lack of perceived benefit of medications
• Knowledge of chronicity of illness
• Knowledge of consequences of illness
• Lack of knowledge about condition
• Lack of medication knowledge
• Misunderstanding of verbal instructions
Medication factors:
• Multiple medications
• Logistical barriers to medication filling
• Adverse drug reactions
Physician factors:
• Poor communication
• Lack of involvement of patients
System-based factors:
• Lack of follow-up
• Lack of medication review
• Lack of patient education
Other factors:
• At least one previous episode of nonadherence
Given that Yap et al [11] identified 80 different factors shown
to influence nonadherence, it seems clear that this problem is
complex and multifactorial. While forgetfulness is often cited
as a reason for medication nonadherence, Saberi et al [10] found
that interventions relying solely on reminding HIV patients to
take their antiretroviral therapy were largely not effective,
leading them to speculate that the attributed forgetfulness was
a simple excuse for more complex underlying reasons like
stigma, depression, drug abuse, and lack of social support.
Across all patient contexts, Brown et al [1] have also concluded
that although most physicians believe nonadherence is due to
forgetfulness or lack of access, it is often a deliberate choice by
the patient.
In the design of any technology, it is critical that special attention
is paid to end-user reactions to the technology. In this case both
patients and providers are end-users. One theory known as the
technology acceptance model has been shown to predict a
substantial portion of the actual use of information technology
in the health care setting [12]. As such, an effective eHealth
intervention should pay special attention to key variables in the
technology acceptance model such as perceived usefulness and
perceived ease of use.
Because the reasons for nonadherence among individual patients
and situations are nuanced and context-driven, designing an
appropriate eHealth intervention provides a significant
challenge. A successful intervention must be able to deconstruct
and reorganize the complex reasons for nonadherence in a way
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that is easily interpretable for providers. Furthermore, the use
of bidirectional SMS or phone call messaging to improve
medication adherence demands that patients and providers be
willing to respond and engage with the system for long periods
of time.
Hypothesis
Recognizing the principles that have emerged from the literature,
we set out to design a stand-alone automated intervention that
would be more functional and cost effective than the current
standard of care. The Epharmix Medication Tracking system,
hereafter referred to as EpxMedTracking, is a medication
adherence eHealth intervention that both reminds patients when
they are supposed to take their medication and goes through a
“differential diagnosis” of why that patient missed their dose
and subsequently alerts their providers. In doing so, we hoped
to give providers real-time insight into when a patient is feeling
sick, out of meds, or may have mistaken beliefs about their
medication regimen. By identifying patients who are not taking
their medication because they feel sick or because the medication
makes them feel sick, the system also has the capacity to detect
adverse drug reactions as they occur. In this study, we aimed
to evaluate the feasibility of the EpxMedTracking system as a
tool to improve medication adherence in terms of its





To assess the feasibility of using EpxMedTracking we analyzed
de-identified aggregate data provided by Epharmix, an outside
telehealth vendor that specializes in designing condition-specific,
automated text messages that are optimized for both clinical
utility and patient engagement. We piloted the system for 17.5
weeks and then made content changes based on feedback from
current users and feedback from a focus group of other low
socioeconomic status (SES) patients (specifically patients with
HIV) and their case managers. This feedback was used to inform
the design of the smart engagement module which included
specific message wording and rotating greeting messages to
improve patient engagement with the system. We specifically
chose to solicit input from HIV patients and their case managers
because this is a patient population where medication adherence
is critical. As such we see it as an important population for
future implementation of EpxMedTracking and studies to
validate its efficacy. Following the implementation of those
changes the official study period began.
Participants
Because we used convenience sampling, we did not use specific
eligibility criteria. Literacy was also not an eligibility criterion
as all text message wording was scored at less than a 6th grade
reading level as determined by the Flesch-Kincaid Grade Level
scale. SMS literacy was a de facto eligibility criteria.
Patients included in both the pilot and study came from the
commercial implementation of the system by several different
provider groups that purchased the Epharmix service to improve
the management of their patients. Thus we used convenience
sampling of the data that we had access to, and recruitment to
the study was handled by the providers themselves and not by
the research team or Epharmix. Participants were therefore
recruited remotely and offline from a clinic and were anonymous
to the research team and Epharmix. Because this was a quality
improvement project and not an institutional review
board–approved trial, participants were not required to fill out
informed consent and were briefed for recruitment at the
discretion of their provider. Having multiple identities was not
possible given the technical capacity of the Epharmix servers.
Institutional affiliation with Washington University was not
displayed to patients. Provider groups included in this study
include two groups from St. Louis, Missouri, and one group
from Georgia.
Intervention
The intervention was developed as a collaboration between
independent researchers and Epharmix, an independent company
and owner of the software. Epharmix has sponsored a research
center at Washington University School of Medicine to foster
the design and development of eHealth interventions. We piloted
the system for a period of 17.5 weeks (123 days) and 3324 total
sessions. During the pilot period, we solicited feedback from
patients enrolled in the system and found that many of them
reported that interacting with the system felt like they were
talking to a machine. Based on this feedback we added a smart
engagement module, which includes encouraging messaging
and phrasing that enables the service to take on the role of
patient advocate and supporter. The smart engagement module
also included rotating greeting messages (see Multimedia
Appendix 1) to initiate text message interactions to add a degree
of novelty for patients. The smart engagement module was
included in the EpxMedTracking intervention for all patients
using the system following the pilot period. Particular attention
was also paid to designing messages that would be effective
even for patients with low health literacy. In designing the smart
engagement module, we also interviewed 5 low SES HIV
patients not currently enrolled in the system and their case
managers to solicit input on message wording and what they
would want out of an SMS medication tracking system. We
chose this particular demographic because we felt it would be
a high-yield demographic for future use of the system and future
studies to verify its efficacy using clinical outcome measures,
such as tracking viral titers. The categories of nonadherence
included “I forgot,” “I felt sick,” “out of meds,” “I am no longer
taking,” “I felt better,” and “other.” These categories of
nonadherence were designed in collaboration with two practicing
physicians.
After the smart engagement module was added, we ended the
pilot period and began the study period immediately with no
washout period. For the pilot study, 26 patients were enrolled.
Of those, 9 were deleted by their provider including 2 that opted
out on their own before being deleted. Of those patients, 8 had
scheduled stops (whereby the provider only prescribed
EpxMedTracking for a certain period of time after which they
discontinued use of the system). A total of 9 patients from the
pilot continued on to the study of EpxMedTracking, and 16 new
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patients were added after the pilot during the study period. Thus
there were 25 total patients included in the study over a period
of 11 weeks. The 9 patients studied in the official study period
that had already been enrolled in the pilot were enrolled in the
pilot for an average of 35.2 (SD 22.9) weeks.
Patients accessed the app by receiving an SMS message on their
phone. Messages were free of charge to all patients and patients
did not need to be a part of a special group to receive them.
Providers accessed the platform via the Web portal [13] directly.
A screenshot from the Web portal is depicted in Figure 1.
Epharmix monitors the message gateway status, and any major
technical errors are accounted for when calculating the
responses. In the case of the study, no major errors occurred. A
patient who does not receive messages due to technology-based
errors (poor cell reception, lack of SMS service, incorrect phone
number entered into the system) would be displayed on the
provider dashboard as unengaged, prompting provider follow-up
to solve the technical problem. Epharmix receives delivery status
reports for all messages sent to ensure their deliverability, and
future iterations of EpxMedTracking will generate an internal
alert at Epharmix for multiple undelivered messages to address
these technical problems without provider involvement.
EpxMedTracking implemented a medication adherence
assessment of patients that then engaged providers using a
triaged report and alert system developed by Epharmix.
Functionally, EpxMedTracking assessed patient medication
adherence via question and then triaged for common possibilities
of nonadherence. Based on responses, it then reported back to
the provider actionable information to facilitate provider
intervention and rapid return to an appropriate medication
regimen. Provider workflow of EpxMedTracking is depicted
in Figure 2. A more detailed workflow of the text messages is
depicted in Figure 3.
The frequency of messages was determined by the provider
based on the frequency of medication doses that patients were
required to take. For this study, care providers were free to
access the Epharmix platform as often as they saw fit and were
free to offer assistance to patients with issues in whatever way
they deemed appropriate. No prompts were used to remind either
patients or providers to use the app. Epharmix staff trained and
supported providers using the software. Providers introduced
the Epharmix software to their patients and trained them to use
it as they saw fit.
Figure 1. Web portal.
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Figure 2. The workflow of messages and care managers used in EpxMedTracking. (A) Patients are initiated on EpxMedTracking with verbal consent
to use. (B) EpxMedTracking assesses medication adherence and common issues. (C) A triage engine determines which patients can be aided in medication
adherence (eg, running out of medication, a medication side effect) and care managers reach out to close the loop. Figure courtesy of Epharmix.
Figure 3. Text message workflow of the EpxMedTracking system.
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Our primary outcome was patient engagement rate which was
calculated as the number of unique patients who responded at
least once divided by the number of unique patients with
sessions scheduled in a given time frame (weeks or days).
Secondary outcomes included the reported reasons for missing
doses in the pilot and the study period and self-reported
medication adherence in the study period. Self-reported
medication adherence was calculated as the number of patients
reporting that they took their medication on a given day divided
by the number of total sessions in that day. Patients were
considered nonadherent if they reported missing a dose or did
not respond to the message. Patients were able to respond to a
message and report adherence to a given dose of medication at
any point between when they received the medication reminder
text for the dose in question to the time in which they received
their medication reminder text for their next dose. Normalized
days 74 to 76 were excluded from the graph because they
included data from fewer than 10 patients. Message engagement,
reasons for missing, and medication adherence data were
collected by querying the Epharmix server.
Sample Size
We did not calculate a necessary sample size for this study. We
used convenience sampling of all of the patient data generated
to date from the EpxMedTracking system.
Statistical Methods
Patients who were deleted by their provider, opted out of
messages on their own, or had a scheduled stop in the delivery
of messages were included in the calculations of engagement
rate, missed doses, and self-reported adherence until the point
at which they stopped receiving messages. Patients who did not
respond to the app but continued to receive messages were
included in all calculations.
Ethics and Informed Consent
Because this was a service improvement project and postmarket
evaluation of an existing system and not an institutional review
board–approved trial, there were no informed consent procedures
for enrollment into the study. The data analyzed was
de-identified to protect patient privacy. Best practices in data
protection and Health Insurance Portability and Accountability
Act compliance were used by Epharmix in the use of
communications with patients.
Results
A total of 2065 sessions were analyzed from 25 different patients
over the study period. Of the 25 patients, 3 never responded to
the system. Of those 3 unresponsive patients, 2 patients were
deleted and 1 patient opted out during the study period. The
engagement rate normalized to weeks on the system was
calculated (Figure 4). There were 198 unique patient-week
combinations over the 11 weeks. Of those 198 patient-weeks,
a patient was enrolled but did not respond at all in a given week
28 times for an overall weekly engagement rate of 85.9%. The
engagement rate over the same time period normalized by day
is presented in Figure 5. This overall engagement rate was higher
than the overall weekly engagement rate observed in the pilot,
which was 73.3% (51 patients enrolled but not responding out
of 191 patient-weeks).
There were 109 reported missed doses (Figure 6). The causes
for missed doses in order of frequency were “I forgot” at 33
events (30.3%), followed by “I felt better” at 29 events (26.6%),
“out of meds” at 20 events (18.4%), “I felt sick” at 19 events
(17.4%), and “other” at 3 events (2.8%). No patients responded
with “I am no longer taking.” An additional 5 missed doses
occurred where the patient responded that the medication was
not taken but they did not respond why. Such events are labeled
in the chart as “Unknown.” We also noted an overall increase
in self-reported medication adherence in patients using the
EpxMedTracking system during the study period (Figure 7).
Figure 4. Patient engagement rates to EpxMedTracking normalized by week during the study period.
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Figure 5. Patient engagement rate over time normalized by day.
Figure 6. Reasons reported for missing medication doses in both the pilot and study period of EpxMedTracking.
Figure 7. Self-reported medication adherence of patients who responded to the EpxMedTracking system.
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We set out to evaluate the feasibility of the EpxMedTracking
system as a tool to improve medication adherence in terms of
its acceptability by patients and its ability to determine why
patients are missing doses. Our data suggest that the
EpxMedTracking system is well received by patients as
demonstrated by the high engagement rate of 85.9% (Figure 4)
observed throughout the study period. This engagement rate
remains high across the 11-week study period and never drops
below 75%, indicating the EpxMedTracking intervention may
be an effective tool for the longitudinal management of
medication adherence in chronic conditions, which as mentioned
previously are particularly susceptible to nonadherence [2].
A distinct strength of our system seems to be detecting when
there is an actionable problem with a patient’s regimen, as 62.4%
of the missed doses were due to “out of meds,” “felt better,” or
“felt sick” (Figure 6). Importantly, this indicates that the
EpxMedTracking system can be used to direct provider attention
to where it is both needed and most useful, thus making the
system well suited to improve the efficiency of provider time
and clinical outcomes in a wide range of disease states where
nonadherence may be an issue.
Improvements in self-reported adherence on the
EpxMedTracking system indicate that enrollment in this system
may also be able to change patient behavior over time (Figure
7). Future studies will look to expand on this possibility and see
if system adoption corresponds to changes in relevant disease
outcome measures such as viral titers in HIV patients.
Comparison With Prior Work
In an analysis of phone call and SMS medication adherence
interventions by Kashgary et al [6], many SMS- and phone
call–based interventions to date have not been automated and
required direct or manual messaging by a human provider
[14,15]. This makes them useful for certain high-risk populations
but prohibitively expensive and time-intensive in most clinical
contexts. Of those that are automated, interventions often use
only basic reminding [16] and thus only address the
forgetfulness aspect of the complex and multidimensional
problem of nonadherence, which only accounts for 30.3% of
missed medication reasons in our sample. As such, the relatively
low frequency of “I forgot” responses (30.3%) seems to support
the theories of Saberi et al [10] and Brown et al [1] discussed
above as they claim nonadherence is a complex,
multidimensional problem that is not sufficiently explained by
just forgetfulness.
While the technology and intervention described here are not
novel, the nature of the intervention is novel. To date, the
EpxMedTracking system is the first SMS-based intervention to
both provide functional medication reminders and categorically
identify problems leading to medication nonadherence, while
simultaneously facilitating bidirectional patient-provider
interaction. The categorical identification of patients who have
actionable problems related to nonadherence allows the system
to functionally identify and separate those nonadherent patients
who would benefit from provider attention from those who are
merely forgetful. In theory this should lead to more targeted
and effective provider intervention in the realm of medication
adherence and improved patient outcomes in a way that would
be impossible with other text message–based medication
adherence systems. As such, our subsequent work will evaluate
the effectiveness of the EpxMedTracking system in terms of
patient outcomes.
Given the improvement in overall engagement noted during our
iterative development of EpxMedTracking from the pilot, this
study shows that it might be possible that patient behavior can
be affected by variations in wording and messages. This
importantly could indicate that 2 digital health interventions
with largely the same substance may produce significantly
different results if they use slight variations in messages and
wording. As such, it may be difficult to accurately make broad
claims about eHealth and digital health. In order to establish
evidence-based protocols for optimizing eHealth in the future,
it may be wise to evaluate all digital health and eHealth
interventions narrowly and in terms of the specific wording they
use. This is also relevant in the context of prior work as it may
provide an explanation for any inconsistencies existing in the
current literature.
Unlike many other eHealth interventions, the EpxMedTracking
system has the added strengths of being highly accessible for
even the most socioeconomically disadvantaged patients because
the system is inexpensive to operate and all messages are free
to patients. The messages are accessible by anyone with a
landline or cell phone, and no smartphone is necessary. This
stands as a significant advantage of the EpxMedTracking system
and other SMS- or phone call–based systems over mobile device
app-based systems. App-based systems are often more complex
and require smartphones and Internet connectivity which may
cause problems with elderly or socioeconomically disadvantaged
populations [17]. Additionally, apps may be less prone to patient
engagement because a user must continue to choose to use the
app, whereas with SMS or phone calls, patients must actively
opt out of receiving messages or continuously ignore incoming
messages [17].
Generalizability
Because our analysis includes data from multiple commercial
accounts, our data thus necessarily includes multiple different
providers and styles of practicing medicine. This indicates that
the results detected in this study are not provider- or practice
setting–specific and externally valid for other organizations.
Given that our data come from use in routine clinical practice,
there are no specially structured elements specific to this study
that could have an effect on use, adoption, or outcomes outside
of this study setting.
Limitations
Although only 30.3% of participants reported missing doses
because they forgot, it is important to realize that there are
alternative explanations for this finding based on the limitations
of the study. For example, it is possible that this finding could
at least partially be explained by patients not wanting to confess
that they forgot to take their medications to their provider,
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instead perhaps opting to not respond or even deliberately
choosing a false response. However, the fact that 30.3% of the
time patients reported missing a dose because they forgot when
there is no appreciable incentive for doing so suggests that
patients engaging with EpxMedTracking probably respond as
truthfully as they would in person.
It is also tempting to speculate that patients may feel less
compelled to respond when they remember to take their
medication and instead use the system for basic reminding and
signaling to their provider when there is a problem with their
regimen. Thus it is possible that the actual engagement rate
could be higher than that observed in this study. In the future,
we hope to explore these possibilities and better understand the
patient experience using EpxMedTracking by administering
anonymous surveys and comparing patient responses to
medication refill data to validate the accuracy of the system and
the honesty of patients using it.
While the results of this study show that enrollment in
EpxMedTracking may be able to improve patient medication
adherence over time (Figure 7), it is also possible that enrollment
in telehealth interventions in general may be able to produce
those kinds of changes. Because we obtained de-identified
information, we also cannot comment on the patient
demographics or disease states included in this study and the
applicability of EpxMedTracking to different patient
populations. Because patients come from both Missouri and
Georgia, we do at least know that these findings are not
community-specific. We also used convenience sampling for
all of our analysis, and there was no control group and no
washout period in between our pilot and the study period. Many
of these limitations are inherent in a service improvement project
with the currently available data, and we hope to address them
in the future with more comprehensive trials.
Conclusions
The evidence presented here shows that the EpxMedTracking
system is a feasible tool that remains reliable over time and is
useful for tracking self-reported medication adherence and
identifying actionable problems with medication adherence in
real time. Our data also raises the possibility that the wording
and message algorithms of eHealth interventions might affect
patient engagement and behavior, which would have important
implications for the design of future eHealth interventions as
well as the evaluation of the eHealth literature to date.
Despite a growing appreciation for the potential of eHealth in
improving medication adherence, much work remains to be
done before we realize its full potential. Further understanding
in these areas has the ability to radically change our
understanding of how patients and providers interact and shift
the paradigm of how we monitor and treat medication
nonadherence as well as countless other conditions.
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